Literature DB >> 17956952

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

Yang Gu1, David F Lewis, Yuping Wang.   

Abstract

CONTEXT: Increased production of antiangiogenic factors soluble endoglin (sEng) and soluble fms-like tyrosine kinase receptor-1 (sFlt-1) by the placenta contributes to the pathophysiology in preeclampsia (PE).
OBJECTIVE: Our objective was to determine the differences in endoglin (Eng), fms-like tyrosine kinase receptor-1 (Flt-1), and placental growth factor (PlGF) expressions between normal and PE placentas and sEng, sFlt-1, and PlGF production by trophoblast cells (TC) cultured under lowered oxygen conditions.
METHODS: TCs isolated from normal and PE placentas were cultured under regular (5% CO2/air) and lowered (2% O2/5% CO2/93% N2) oxygen conditions. sEng, sFlt-1, and PlGF productions were determined by ELISA. Protein expressions for Eng, Flt-1, and PlGF in the placental tissues were accessed by immunohistochemical staining and Western blot analysis. Deglycosylated Eng, Flt-1, and PlGF protein expressions in placental tissues were also examined.
RESULTS: PE TCs produced significantly more sEng, sFlt-1, and PlGF compared with those from normal TCs (P < 0.05). Under lowered oxygen conditions, PE TCs, but not normal TCs, released more sEng and sFlt-1. In contrast, both normal and PE TCs released less PlGF (P < 0.05). Enhanced expressions of Eng and Flt-1, as well as glycosylated Eng and Flt-1, were observed in PE placentas. Immunoblot also revealed that TCs released glycosylated sFlt-1, but not sEng, in culture.
CONCLUSIONS: PE TCs produce more sEng, sFlt-1, and PlGF than normal TCs. Lowered oxygen conditions promote sEng and sFlt-1, but reduce PlGF, productions by PE TCs. More glycosylated sEng and sFlt-1 are present in PE placentas. Trophoblasts release glycosylated sFlt-1, but unglycosylated sEng, in culture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956952      PMCID: PMC2190747          DOI: 10.1210/jc.2007-1550

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

Authors:  R L Kendall; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

2.  Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.

Authors:  A Gougos; M Letarte
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

3.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Differential interactions of human choriogonadotropin and its antagonistic aglycosylated analog with their receptor.

Authors:  I Ji; T H Ji
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

6.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

Authors:  J E Park; H H Chen; J Winer; K A Houck; N Ferrara
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

7.  Placental prostacyclin production in normal and toxemic pregnancies.

Authors:  S W Walsh; M J Behr; N H Allen
Journal:  Am J Obstet Gynecol       Date:  1985-01-01       Impact factor: 8.661

8.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.

Authors:  Monica Autiero; Johannes Waltenberger; Didier Communi; Andrea Kranz; Lieve Moons; Diether Lambrechts; Jens Kroll; Stephane Plaisance; Maria De Mol; Françoise Bono; Stefanie Kliche; Guido Fellbrich; Kurt Ballmer-Hofer; Domenico Maglione; Ulrike Mayr-Beyrle; Mieke Dewerchin; Saskia Dombrowski; Danica Stanimirovic; Paul Van Hummelen; Christoph Dehio; Daniel J Hicklin; Graziella Persico; Jean-Marc Herbert; David Communi; Masabumi Shibuya; Désiré Collen; Edward M Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 9.  Protein glycosylation. Structural and functional aspects.

Authors:  H Lis; N Sharon
Journal:  Eur J Biochem       Date:  1993-11-15

10.  Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia.

Authors:  S W Walsh; Y Wang
Journal:  J Clin Endocrinol Metab       Date:  1995-06       Impact factor: 5.958

View more
  49 in total

1.  Proteases and sFlt-1 release in the human placenta.

Authors:  S Zhao; Y Gu; R Fan; L J Groome; D Cooper; Y Wang
Journal:  Placenta       Date:  2010-06       Impact factor: 3.481

2.  Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.

Authors:  S Guller; Z Tang; Y Y Ma; S Di Santo; R Sager; H Schneider
Journal:  Placenta       Date:  2010-11-11       Impact factor: 3.481

Review 3.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

4.  D2-40/podoplanin expression in the human placenta.

Authors:  Y Wang; J Sun; Y Gu; S Zhao; L J Groome; J S Alexander
Journal:  Placenta       Date:  2010-11-20       Impact factor: 3.481

5.  ADAM17 regulates TNFα production by placental trophoblasts.

Authors:  R Ma; Y Gu; L J Groome; Y Wang
Journal:  Placenta       Date:  2011-10-20       Impact factor: 3.481

6.  A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Adi Tarca; Juan Pedro Kusanovic; Pooja Mittal; Sun Kwon Kim; Francesca Gotsch; Offer Erez; Edi Vaisbuch; Shali Mazaki-Tovi; Percy Pacora; Giovanna Ogge; Zhong Dong; Chong Jai Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

7.  Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.

Authors:  Jeffry Iman Gurnadi; Johannes Mose; Budi Handono; Mieke H Satari; Anita Deborah Anwar; Prima Nanda Fauziah; A Yogi Pramatirta; Dwi Davidson Rihibiha
Journal:  BMC Res Notes       Date:  2015-10-04

8.  Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression.

Authors:  Jeffrey S Gilbert; Sara A B Gilbert; Marietta Arany; Joey P Granger
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

9.  Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia.

Authors:  Akitoshi Nakashima; Mikiko Yamanaka-Tatematsu; Naonobu Fujita; Keiichi Koizumi; Tomoko Shima; Toshiko Yoshida; Toshio Nikaido; Aikou Okamoto; Tamotsu Yoshimori; Shigeru Saito
Journal:  Autophagy       Date:  2013-01-15       Impact factor: 16.016

10.  Decreased levels of folate receptor-β and reduced numbers of fetal macrophages (Hofbauer cells) in placentas from pregnancies with severe pre-eclampsia.

Authors:  Zhonghua Tang; Irina A Buhimschi; Catalin S Buhimschi; Serkalem Tadesse; Errol Norwitz; Tracy Niven-Fairchild; Se-Te J Huang; Seth Guller
Journal:  Am J Reprod Immunol       Date:  2013-03-11       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.